Overview

Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of TLK199 Tablets in patients with Myelodysplastic Syndrome (MDS)
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Telik